Cytek® Biosciences is a leading cell analysis solutions company advancing the next generation of tools with patented Full Spectrum Profiling™ (FSP™) technology. Cytek’s portfolio includes the Cytek Aurora™, Cytek Aurora™ CS and Cytek Northern Lights™ systems, Amnis® and Guava® products, reagents, software, and services to provide comprehensive solutions for customers.

Prokarium is a clinical-stage biopharmaceutical company bioengineering Living Cures through advanced synthetic biology. Our lead program, progressing through US clinical trials for bladder cancer, introduces a single-dose therapy redesigning the treatment paradigm for patients. Prokarium's innovative Living Cures platform aims to transform precision medicine with off-the-shelf programmable therapeutics, establishing a new class of immunotherapies.

Founded in 2023, Kincell Bio’s mission is to be a trusted manufacturing services partner for early-stage cell therapy companies by providing access to CMC development and clinical manufacturing services for emerging leaders in cell therapy. 

Headquartered in Gainesville, Florida, Kincell is a technology-forward contract development and manufacturing organization (CDMO) dedicated to streamline analytical development, process development, CMC consulting and early-stage GMP cell therapy manufacturing. Kincell’s primary focus is to aggregate technology, experiences and ambitions to manufacture commercially viable immune cell therapies, including autologous and allogeneic CAR-T, CAR-NK and CAR-M programs.

TriStar is a biotechnology company specializing in the provision of quality annotated human oncology biospecimens and integrated, in-house contract research services (IHC, RNA-ISH, WES & RNAseq) for pharma, biotech, and diagnostic developers. Our ethically approved anonymized clinical samples acquired via collaborations with leading UK & European medical centers include pre/post SOC & immunotherapy, and incorporate clinical follow-up, survival & response information. TriStar’s expansive collection of FFPE blocks, tissue microarrays (TMAs), plasma, and digital images include IHC, NGS, RNAseq, GeoMx DSP & CODEX characterized specimens to facilitate a deeper understanding of tumor immune biology and to support drug development research in oncology & immuno-oncology.

Akamis Bio is a clinical-stage oncology company aiming to transform treatment of advanced solid tumors by designing novel, systemically administered viruses that can deliver potent, immunomodulatory therapeutics directly into tumors to treat previously intractable cancers.

Picture Health creates multimodal AI biomarkers for precision oncology via our proprietary Px Platform with next-generation radiomics capabilities.  Our advanced radiomic and pathomic imaging features, demonstrated in over 80 peer reviewed papers, are tied to interpretable biological tumor characteristics. Picture Health partners with biopharma companies to improve patient characterization & selection using small datasets from Phase 1 and 2 clinical trials. The Px Platform enables us to develop custom predictive AI biomarkers tailored to a specific indication. For more information, go to https://picturehealth.com/

N-Power Medicine is expanding access to oncology clinical trials across a network of community practices. N-Power Medicine provides clinical research infrastructure, including staff and technology, across all patients. This supports sites by standardizing high-quality data in a real-time registry at the point of care, facilitating patient identification and clinical trial conduct. For more information, go to https://www.npowermedicine.com/

Connecting the world with the right doctors, and doctors to a world of research. The trusted source of truth for global healthcare professional (HCP), clinical, scientific, and research information for life sciences, payors, providers, and patients. For more information, go to https://h1.co/

CRIO revolutionizes clinical research with cutting-edge cloud technology. CRIO enables remote monitoring and instant data review with CRIO Reviewer, an integrated eSource/EDC solution. Capturing data in real-time and ensuring compliance with various regulations, including 21 CFR 11, ICH-GCP, GDPR, and HIPAA, CRIO eliminates redundant data entry and safeguards data integrity. For more information, please visit https://clinicalresearch.io/

Bold thinking. Bolder actions. We are Medtronic.

We lead global healthcare technology and boldly attack the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ passionate people. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world.

In everything we do, we are engineering the extraordinary.

EvolveImmune Therapeutics is a development-stage immune-oncology company which is pioneering an entirely new category of Precision Oncology medicines designed to overcome cancer cell resistance to current anti-tumor therapies. Our proprietary EVOLVE trispecific T cell engager platform fully integrates T cell costimulation through the CD2 receptor in a single biotherapeutic molecule, to optimize T cells for deep and durable clinical responses. To learn more, please visit https://evolveimmune.com.